(Total Views: 380)
Posted On: 06/17/2019 1:46:35 PM
Post# of 149074
New PI Video:
https://www.proactiveinvestors.com/companies/...13768.html
Summary:
1) NP is back in the office
2) Discusses PrEP Thai study; could very quick process to prevention approval (post combo approval); seems like they are trying to put the pressure on Gilead; less side affects on Leronlimab compared to Truvada.
3) Trial outline: 50 patients initially potentially from large center that tests 40,000 patients checked on regular basis; protocol still in design; hope to begin study this year.
https://www.proactiveinvestors.com/companies/...13768.html
Summary:
1) NP is back in the office
2) Discusses PrEP Thai study; could very quick process to prevention approval (post combo approval); seems like they are trying to put the pressure on Gilead; less side affects on Leronlimab compared to Truvada.
3) Trial outline: 50 patients initially potentially from large center that tests 40,000 patients checked on regular basis; protocol still in design; hope to begin study this year.
(0)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
Scroll down for more posts ▼
